Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Sarah Chamlin MD
Sarah L. Chamlin MD Advisory Board
Christen Mowad MD
Christen Maria Mowad MD Advisory Board
Jane Grant-Kels MD, FAAD
Jane M. Grant-Kels MD, FAAD Advisory Board
See All Experts
featured
Published in Dermatology

Expert Opinion / Commentary · December 05, 2016

2016 Top Stories in Dermatology: Infantile Hemangiomas: We Have Come a Long Way

Sarah Chamlin MD

 

 Save  Recommend
 Share

Additional Info

  1. Baselga E, Roe E, Coulie J, et al. Risk factors for degree and type of sequelae after involution of untreated hemangiomas of infancy. JAMA Dermatol. 2016;152(11):1239-1243.
  2. Shah SD, Baselga E, McCuaig C, et al. Rebound growth of infantile hemangiomas after propranolol therapy. Pediatrics. 2016;137(4):e20151754.
  3. Frommelt P, Juern A, Siegel D, et al. Adverse events in young and preterm infants receiving topical timolol for infantile hemangioma. Pediatr Dermatol. 2016;33(4):405-414.
  4. Püttgen K, Lucky A, Adams D, et al. Topical timolol maleate treatment of infantile hemangiomas. Pediatrics. 2016;138(3):e20160355.
  5. Wedgeworth E, Glover M, Irvine AD, et al. Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey. Br J Dermatol. 2016;174(3):594-601.
  6. Léaute-Labrèze C, Boccara O, Degrugillier-Chopinet C, et al. Safety of oral propranolol for the treatment of infantile hemangioma: a systematic review. Pediatrics. 2016;138(4):e20160353.
  7. Yanes DA, Pearson GD, Witman PM. Infantile hemangiomas of the lip: patterns, outcomes, and implications. Pediatr Dermatol. 2016;33(5):511-517.

Disclosure statements are available on the authors' profiles:

Sarah Chamlin MD

Further Reading

Most Read This Week

Recently Updated